| 000 | 01768 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514004804.0 | ||
| 264 | 0 | _c20010830 | |
| 008 | 200108s 0 0 eng d | ||
| 022 | _a0344-5704 | ||
| 024 | 7 |
_a10.1007/s002800100293 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLara, P N | |
| 245 | 0 | 0 |
_aActivity of high-dose toremifene plus cisplatin in platinum-treated non-small-cell lung cancer: a phase II California Cancer Consortium Trial. _h[electronic resource] |
| 260 |
_bCancer chemotherapy and pharmacology _cJul 2001 |
||
| 300 |
_a22-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenes, fos |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aProtein Kinase C _xmetabolism |
| 650 | 0 | 4 |
_aToremifene _xadministration & dosage |
| 700 | 1 | _aGandara, D R | |
| 700 | 1 | _aLongmate, J | |
| 700 | 1 | _aGumerlock, P H | |
| 700 | 1 | _aLau, D H | |
| 700 | 1 | _aEdelman, M J | |
| 700 | 1 | _aGandour-Edwards, R | |
| 700 | 1 | _aMack, P C | |
| 700 | 1 | _aIsrael, V | |
| 700 | 1 | _aRaschko, J | |
| 700 | 1 | _aFrankel, P | |
| 700 | 1 | _aPerez, E A | |
| 700 | 1 | _aLenz, H J | |
| 700 | 1 | _aDoroshow, J H | |
| 773 | 0 |
_tCancer chemotherapy and pharmacology _gvol. 48 _gno. 1 _gp. 22-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s002800100293 _zAvailable from publisher's website |
| 999 |
_c11415370 _d11415370 |
||